Skip to main content
Top
Published in: Critical Care 3/2002

Open Access 01-06-2002 | Research

Pruritus: a useful sign for predicting the haemodynamic changes that occur following administration of vancomycin

Authors: Massimo Bertolissi, Flavio Bassi, Roberta Cecotti, Carlo Capelli, Francesco Giordano

Published in: Critical Care | Issue 3/2002

Login to get access

Abstract

Introduction

The aim of this study was to investigate the haemodynamic changes that follow the appearance of pruritus during vancomycin administration.

Methods

We studied 50 patients scheduled for coronary artery bypass surgery, and we compared data from patients who exhibited pruritus with those from patients who did not. After the monitoring devices had been positioned, vancomycin (15 mg/kg) was continuously infused at a constant rate over 30 min, before induction of anaesthesia. Haemodynamic profiles were recorded before vancomycin infusion (time point 1); at 15 (time point 2) and 30 min (time point 3) after the beginning of vancomycin infusion; and 15 min after vancomycin infusion had been stopped (time point 4). At each time arterial and mixed venous blood samples were drawn to calculate the shunt fraction (Qsp/Qt).

Results

In patients who exhibited pruritus (group A, n = 17) at time point 3 versus time point 1, systemic vascular resistance index (SVRI) and arterial oxygen tension (PaO2) decreased significantly; cardiac index (CI), stroke volume index (SVI) and Qsp/Qt increased significantly; and mean systemic pressure and heart rate were stable. Those changes were observed only in patients not treated with a β-blocker before surgery, whereas no change occurred in patients treated with the drug. In the patients who were free from pruritus (group B, n = 28), we did not observe any significant change.

Conclusion

The appearance of pruritus during vancomycin administration indicates that SVRI is declining, thus exposing the patient to risk for hypotension. Therapy with a β-blocker appears to confer protection against this hemodynamic reaction.
Literature
1.
go back to reference Fekety R: Vancomycin and teicoplanin. In Principles and Practice of Infectious Disease. (Edited by: Mandell GL, Bennett JE, Dolin R). New York: Churchill Livingstone 1995, 346-354. Fekety R: Vancomycin and teicoplanin. In Principles and Practice of Infectious Disease. (Edited by: Mandell GL, Bennett JE, Dolin R). New York: Churchill Livingstone 1995, 346-354.
2.
go back to reference Wilhelm MP, Estes L: Symposium on antimicrobal agents: van–comycin. Mayo Clin Proc 1999, 74: 928-935.CrossRefPubMed Wilhelm MP, Estes L: Symposium on antimicrobal agents: van–comycin. Mayo Clin Proc 1999, 74: 928-935.CrossRefPubMed
4.
go back to reference Leader WG, Chandler MH, Castiglia M: Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet 1995, 28: 327-342.CrossRefPubMed Leader WG, Chandler MH, Castiglia M: Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet 1995, 28: 327-342.CrossRefPubMed
5.
go back to reference Romanelli VA, Howie MB, Myerowitz PD, Zvara DA, Rezaei A, Jackman DL, Sinclair DS, McSweeney TD: Intraoperative and postoperative effects of vancomycin administration in cardiac surgery patients: a prospective, double-blind, randomised trial. Crit Care Med 1993, 21: 1124-1131.CrossRefPubMed Romanelli VA, Howie MB, Myerowitz PD, Zvara DA, Rezaei A, Jackman DL, Sinclair DS, McSweeney TD: Intraoperative and postoperative effects of vancomycin administration in cardiac surgery patients: a prospective, double-blind, randomised trial. Crit Care Med 1993, 21: 1124-1131.CrossRefPubMed
6.
go back to reference Rosemberg JM, Wahr JA, Smith KA: Effects of vancomycin infusion on cardiac function in patients scheduled for cardiac operations. J Thorac Cardiovasc Surg 1995, 109: 561-564.CrossRef Rosemberg JM, Wahr JA, Smith KA: Effects of vancomycin infusion on cardiac function in patients scheduled for cardiac operations. J Thorac Cardiovasc Surg 1995, 109: 561-564.CrossRef
7.
go back to reference Valero R, Gomar C, Fita G, Gonzalez M, Pacheco M, Mulet J, Nalda MA: Adverse reactions to vancomycin prophylaxis in cardiac surgery. J Cardiothorac Vasc Anesth 1991, 5: 574-576.CrossRefPubMed Valero R, Gomar C, Fita G, Gonzalez M, Pacheco M, Mulet J, Nalda MA: Adverse reactions to vancomycin prophylaxis in cardiac surgery. J Cardiothorac Vasc Anesth 1991, 5: 574-576.CrossRefPubMed
8.
go back to reference Southorn PA, Plevak DJ, Wright AJ, Wilson WR: Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 1986, 61: 721-724.CrossRefPubMed Southorn PA, Plevak DJ, Wright AJ, Wilson WR: Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 1986, 61: 721-724.CrossRefPubMed
9.
go back to reference von Kaenel WE, Bloomfield EL, Amaranath L, Wilde AA: Van-comycin does not enhance hypotension under anesthesia. Anesth Analg 1993, 76: 809-811.PubMed von Kaenel WE, Bloomfield EL, Amaranath L, Wilde AA: Van-comycin does not enhance hypotension under anesthesia. Anesth Analg 1993, 76: 809-811.PubMed
10.
go back to reference Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J: Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998, 89: 620-625. 10.1097/00000542-199809000-00010CrossRefPubMed Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J: Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998, 89: 620-625. 10.1097/00000542-199809000-00010CrossRefPubMed
11.
go back to reference Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J: Oral antihistamines reduce the side effects from rapid vancomycin infusion. Anesth Analg 1998, 87: 681-685.PubMed Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J: Oral antihistamines reduce the side effects from rapid vancomycin infusion. Anesth Analg 1998, 87: 681-685.PubMed
12.
go back to reference Nunn JF: Distribution of pulmonary ventilation and perfusion. In Applied Respiratory Physiology 5 Edition (Edited by: Lumb AB, Nunn JF). Cambridge: Butterworth-Heinemann 1993, 163-199. Nunn JF: Distribution of pulmonary ventilation and perfusion. In Applied Respiratory Physiology 5 Edition (Edited by: Lumb AB, Nunn JF). Cambridge: Butterworth-Heinemann 1993, 163-199.
13.
go back to reference Wallace MR, Mascola JR, Oldfield EC: Red man syndrome: incidence, etiology and prophylaxis. J Infect Dis 1991, 164: 1180-1185.CrossRefPubMed Wallace MR, Mascola JR, Oldfield EC: Red man syndrome: incidence, etiology and prophylaxis. J Infect Dis 1991, 164: 1180-1185.CrossRefPubMed
15.
go back to reference Sahai J, Healy DP, Shelton MJ, Miller JS, Ruberg SJ, Polk R: Comparison of vancomycin and teicoplanin induced histamine release and 'red man syndrome'. Antimicrob Agents Chemother 1990, 34: 765-769.PubMedCentralCrossRefPubMed Sahai J, Healy DP, Shelton MJ, Miller JS, Ruberg SJ, Polk R: Comparison of vancomycin and teicoplanin induced histamine release and 'red man syndrome'. Antimicrob Agents Chemother 1990, 34: 765-769.PubMedCentralCrossRefPubMed
16.
go back to reference Dajee H, Laks H, Miller J, Oren R: Profound hypotension from rapid vancomycin administration during cardiac operation. J Thorac Cardiovasc Surg 1984, 87: 145-146.PubMed Dajee H, Laks H, Miller J, Oren R: Profound hypotension from rapid vancomycin administration during cardiac operation. J Thorac Cardiovasc Surg 1984, 87: 145-146.PubMed
Metadata
Title
Pruritus: a useful sign for predicting the haemodynamic changes that occur following administration of vancomycin
Authors
Massimo Bertolissi
Flavio Bassi
Roberta Cecotti
Carlo Capelli
Francesco Giordano
Publication date
01-06-2002
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1495

Other articles of this Issue 3/2002

Critical Care 3/2002 Go to the issue